Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations

Bibliographic Details
Main Author: Swiss Medical Weekly
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2010-04-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/1111
_version_ 1826996749347061760
author Swiss Medical Weekly
author_facet Swiss Medical Weekly
author_sort Swiss Medical Weekly
collection DOAJ
first_indexed 2024-04-11T12:10:17Z
format Article
id doaj.art-0ded7df986a24fc89da4a29b816bf6a7
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2025-02-18T09:50:30Z
publishDate 2010-04-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-0ded7df986a24fc89da4a29b816bf6a72024-11-02T11:52:49ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972010-04-01140151610.4414/smw.2010.12989Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendationsSwiss Medical Weeklyhttps://www.smw.ch/index.php/smw/article/view/1111bone marrow transplantBortezomibelderlylenalidomidemultiple myelomarelapsed/refractory
spellingShingle Swiss Medical Weekly
Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations
Swiss Medical Weekly
bone marrow transplant
Bortezomib
elderly
lenalidomide
multiple myeloma
relapsed/refractory
title Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations
title_full Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations
title_fullStr Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations
title_full_unstemmed Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations
title_short Integrating novel agents into multiple myeloma treatment – current status in Switzerland and treatment recommendations
title_sort integrating novel agents into multiple myeloma treatment current status in switzerland and treatment recommendations
topic bone marrow transplant
Bortezomib
elderly
lenalidomide
multiple myeloma
relapsed/refractory
url https://www.smw.ch/index.php/smw/article/view/1111
work_keys_str_mv AT swissmedicalweekly integratingnovelagentsintomultiplemyelomatreatmentcurrentstatusinswitzerlandandtreatmentrecommendations